title: Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer.
authors.affiliation: Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden.
authors.forename: Anthoula
authors.initials: A
authors.lastname: Koliadi
authors.forename: Cecilia
authors.initials: C
authors.lastname: Nilsson
authors.forename: Marit
authors.initials: M
authors.lastname: Holmqvist
authors.forename: Lars
authors.initials: L
authors.lastname: Holmberg
authors.forename: Manuel
authors.initials: M
authors.lastname: de La Torre
authors.forename: Fredrik
authors.initials: F
authors.lastname: Wärnberg
authors.forename: Marie-Louise
authors.initials: ML
authors.lastname: Fjällskog
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000401:mortality* / Q000473:pathology; D019926:Cyclin B / Q000032:analysis*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011379:Prognosis; D012372:ROC Curve; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D014408:Biomarkers, Tumor; D019926:Cyclin B